Professor Weijun Fan is currently director of Department of Minimally Invasive Interventional Therapy at Sun Yat-sen University Cancer Center (SYSUCC), Guangzhou, China.  As the leader of the First Tumor Ablation Training Course of the Chinese Medical Doctor Association (CMDA), professor Fan has pioneered the Chinese Medical Doctor Association's tumor ablation training. So far, the Training Course has trained more than 5,000 ablation professionals for all provinces and municipalities across the country. As the leader of the tumor ablation training expert group, he participated in the organization of 29 sessions of ablation training, and organized the compilation of the first set of tumor ablation training materials of the CMDA, which has made great contributions to the cause of tumor ablation in China. Professor Fan Weijun edited the first monograph on microwave ablation of tumors called “Microwave Ablation Therapy for Tumors”, which laid the foundation for the popularization of tumor microwave ablation technology in China. Moreover, he organized the "Expert Consensus for Thermal Ablation for Primary and Metastatic Lung Tumors" and "Expert Consensus for Image-guided Adrenal Tumor Ablation Treatment".  

Professor Fan is currently the chairman of the ablation committee of the CMDA intervention branch; the leader of the tumor ablation treatment technology expert group of the CMDA; the candidate of the chairman of the professional committee member of the tumor ablation treatment of the CHINESE ANTI CANCER ASSOCIATION (CACA); Deputy Director of the Tumor Ablation Therapy Expert Committee of the Chinese Society of Clinical Oncology (CSCO); Chairman of the Respiratory Intervention Special Committee of the Interventional Group of the Chinese Society of Radiology (CSR); the candidate of the chairman of the Professional Committee of Tumor Minimally Invasive Therapy of Guangdong Anticancer Association. Besides, Professor Fan is the Chinese deputy Editor-in-Chief of “Journal of Cancer Research and Therapeutics”. And he also is the editorial board member of "Interventional Radiology" and "Anatomy and Clinical Medicine". At present, he has published fifties of papers.

More than fifty papers were published in core Journals in China, and more than twenty SCI papers were published on multiple magazines, such as Cancer, Aging, Cancer Immunology Immunotherapy, International Journal of Hyperthermia, AJR, and JVIR.

1.Xin Li,Weijun Fan, Liang Zhang, Ming Zhao, Zilin Huang, Wang Li, Yangkui Gu, Fei Gao, Jinhua Huang, Chuanxing Li, Fujun Zhang, Peihong Wu, CT-Guided Percutaneous Microwave Ablation of Adrenal Malignant Carcinoma, Cancer,2011.11.15，117(22):5182~5188

2.Cao F, Shen L, Qi H, Xie L, Song Z, Chen S,Fan W: Tree-based classification system incorporating the HVTT-PVTT score for personalized management of hepatocellular carcinoma patients with macroscopic vascular invasion. Aging (Albany NY) 2019, 11(21):9544-9555. 

3.Shen L, Qi H, Chen S, Cao F, Xie L, Wu Y, Ma W, Song Z, Yuan H, Zhang T, Li D, Wen X, Chen Q, Li W, Zhang X,Fan W. Cryoablation combined with transarterial infusion of pembrolizumab (CATAP) for liver metastases of melanoma: an ambispective, proof-of-concept cohort study. Cancer Immunol Immunother. 2020. doi: 10.1007/s00262-020-02566-z.

4. Fan WeiJun, Li Xin, Zhang Liang, Jiang Hua, Zhang JianLei, Comparison of Microwave Ablation and Multipolar Radiofrequency Ablation In Vivo Using Two Internally Cooled Probes, American Journal of Roentgenology, 2012.1.01，198(1):W46~W50

5.Li Xin, Zhang Liang,Fan Weijun, Zhao Ming, Wang Ligang, Tang Tian, Jiang Hua, Zhang Jianlei, Liu Yanfeng, Comparison of microwave ablation and multipolar radiofrequency ablation, both using a pair of internally cooled interstitial applicators: Results in ex vivo porcine livers, INTERNATIONAL JOURNAL OF HYPERTHERMIA，2011.01.01, 27(3):240~248

6.Xie L, Cao F, Qi H, Song Z, Shen L, Chen S, Hu Y, Chen C,Fan W: Efficacy and safety of CT-guided percutaneous thermal ablation for hepatocellular carcinoma adjacent to the second porta hepatis. Int J Hyperthermia 2019, 36(1):1122-1128.

7.Chen S, Shi M, Shen L, Qi H, Wan W, Cao F, Xie L, Wu Y, Chen G, Mo J, Zhu G, Ye D, Zhang Y, Feng Z, Xu L,Fan W: Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis. Int J Hyperthermia 2020, 37(1):384-391.

8.Li Xin,Fan Weijun, Zhang Liang, Zhang Xiao-ping, Jiang Hua. Zhang  Jian-lei, Zhang Hao, CT-guided Percutaneous Microwave Ablation of Liver Metastases from Nasopharyngeal Carcinoma, JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2013.5.01, 24(5):680~684

9.Qiuxia Yang, Han Qi, Rong Zhang, Chao Wan, Ze Song, Liang Zhang, Weijun Fan. Risk Factors for Local Progression after Percutaneous Radiofrequency Ablation of Lung Tumors: Evaluation Based on a Review of 147 Tumors, J Vasc Interv Radiol，2017.01.19

10.Qi H,Fan W. Value of ablation therapy in the treatment of lung metastases. Thoracic Cancer. 2017 doi:10.1111/1759-7714.12567

11.Cao F, Xie L, Qi H, Chen S, Shen L, Song Z,Fan W: Safety and efficacy of thermal ablation for subpleural lung cancers. THORAC CANCER 2019, 10(6):1340-1347.

12.Cao F, Wan C, Xie L, Qi H, Shen L, Chen S, Song Z,Fan W: Localized RNA interference therapy to eliminate residual lung cancer after incomplete microwave ablation. THORAC CANCER 2019, 10(6):1369-1377.

13.Qiu Z, Shen L, Chen S, Qi H, Cao F, Xie L,Fan W: Efficacy Of Apatinib In Transcatheter Arterial Chemoembolization (TACE) Refractory Intermediate And Advanced-Stage Hepatocellular carcinoma A Propensity Score Matching Analysis. CANCER MANAG RES 2019, 11:9321-9330.

Updated April 2021 by International Office, Sun Yat-sen University Cancer Center